Biofrontera AG Sponsored ADR Operating Cash Flow

Operating Cash Flow of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Cash Flow growth rates and interactive chart. Operating cash flow (OCF) is a measure of the amount of cash generated by a company's normal business operations. Operating cash flow indicates whether a company can generate sufficient positive cash flow to maintain and grow its operations, otherwise it may require external financing for expansion or even survival. A negative number means the company is funded through external capital (debt or equity issuance) or cash available on the balance sheet. A positive number means that a company generates enough cash to pay for its operations.

Highlights and Quick Summary

  • Operating Cash Flow for the quarter ending June 30, 2021 was $-6.77 Million (a 393.55% increase compared to previous quarter)
  • Year-over-year quarterly Operating Cash Flow decreased by -53.21%
  • Annual Operating Cash Flow for 2021 was $36 Million (a 14.04% increase from previous year)
  • Annual Operating Cash Flow for 2021 was $31.6 Million (a -1070.31% decrease from previous year)
  • Annual Operating Cash Flow for 2020 was $-3.25 Million (a -20.23% decrease from previous year)
  • Twelve month Operating Cash Flow ending June 30, 2021 was $-36.3 Million (a 6.87% increase compared to previous quarter)
Trailing Operating Cash Flow for the last four month:
30 Jun '21 30 Jun '20 30 Sep '18 —
$-36.3 Million $-34 Million $-44 Million —
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Cash Flow of Biofrontera AG Sponsored ADR

Most recent Operating Cash Flowof BFAGY including historical data for past 10 years.

Interactive Chart of Operating Cash Flow of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Operating Cash Flow for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 – – – $-6.77 $36.01
2020 – – – $-1.37 $-3.25
2019 – – – – $-36.84
2018 – – – $-13.7 $-15.87
2017 – – $-14.47 $-4.44 $-14.83
2016 $-11.35 – – – $-11.35

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com